Johnson & Johnson (JNJ) Institutional Ownership & Insider Trading

4,664 institutions reported holding Johnson & Johnson shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 30 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-27 · read by EquiReason

JNJJohnson & JohnsonFollow JNJ — free

Drug Manufacturers - General · Healthcare

—

Price chart with a free account

Market cap: 635.1B
P/E TTM: 40.0
Dividend yield: 2.0%
52-week: —
Next earnings: 26 Jan, in 94 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

4,664 institutions held 74.8% of the shares. Across filers that reported both quarters, shares held changed +0.2%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	4,664	1800	+0.2%	1491	132	1374	83
Mar 26	4,570	1767	+0.9%	1265	188	1692	81
Dec 25	4,395	1766	-3.2%	1182	157	1415	63
Sep 25	4,101	1792	+3.6%	1223	205	1310	78
Jun 25	3,996	1747	+0.5%	1161	90	1467	139
Mar 25	4,029	1705	+0.2%	1294	153	1443	98
Dec 24	3,958	1730	-1.4%	1016	81	1577	141
Sep 24	3,771	1686	-2.2%	1098	130	1304	79

Johnson & Johnson — questions

Who owns Johnson & Johnson stock?: 4,664 institutions reported Johnson & Johnson shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.8%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (5.6%).
Are Johnson & Johnson insiders buying or selling?: 30 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Johnson & Johnson's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.